Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I May 15, 2020
Ultragenyx Announces Positive Data from Confirmatory Cohort of Phase 1/2 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa) May 15, 2020
TraceLink Hosts Webinar to Help Pharma Prepare for Supply Chain Disruptions in the “Next Normal” May 14, 2020
Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency May 13, 2020
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma May 13, 2020
SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets – Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting May 12, 2020
Arvelle Therapeutics: SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy May 12, 2020
Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead May 12, 2020